LOS ANGELES, June 8, 2005 (PRIMEZONE) -- Universal Detection Technology (OTCBB:UDTT) -- The Company announced today that it has received Frost & Sullivan's 2005 Technology Leadership Award in the field of biological detection.
Frost & Sullivan's Technology Leadership Award is bestowed upon companies that pioneer the development and introduction of innovative technologies into the market, technologies that have either impacted or have the potential to impact several market sectors. "It is imperative that the importance of our technology is being recognized by the market. We are delighted to be the recipient of this award, which recognizes our unique approach to bio-warfare detection," said Mr. Amir Ettehadieh, UDTT's Director of Research and Development. "Our spore detection technology is designed to provide a solution to the lack of real-time and continuous monitoring techniques for early bio-warfare detection, which is the single most important factor in reducing the dire consequences of a potential bio-terrorist attack," added Mr. Ettehadieh.
"The simplicity and robustness of the UDT bacterial spore detection system make it compatible for monitoring commercial buildings, public facilities, and the like," said Girish Solanki, Research Manager at Frost & Sullivan Technical Insights. "The award basically recognizes Universal Detection Technology's development of a novel technology that is able to effectively detect 'invisible' biological threats," he added.
To view the full award text please visit http://www.udetection.com/articles/frost.htm
About Universal Detection Technology
Universal Detection Technology (UDT), founded in 1973, is a developer of monitoring technologies, including bio-terrorism detection devices. Management believes that the Company's technology, together with third party technologies and devices, has positioned it to capitalize on growth and value opportunities related to Homeland Security. Universal Detection Technology, in cooperation with NASA's Jet Propulsion Laboratory (JPL) has developed a bio-terror 'smoke' detector, which combines JPL's spore detection technology with UDTT's aerosol capture device. For more information, please visit http://udtt.invrel.net or http://www.udetection.com.
About Frost & Sullivan
Frost & Sullivan employs over 400 consultants, market analysts, corporate trainers, account managers and customer support staff globally. They work together in providing growth consulting and corporate training solutions to clients in more than 50 countries around the world. Frost & Sullivan recognizes outstanding industry achievements by presenting Frost & Sullivan Awards to top companies in regional and global markets. Frost and Sullivan's teams of industry experts recognize the diligence and innovation required to implement a successful business plan and excel in the increasingly competitive global marketplace. These prestigious awards are recognized worldwide by the media, the investment community and end-user markets.
Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties include, among other things, the funding of amounts of capital adequate to provide for our working capital needs and our timely repayment of debt, our ability to timely and cost effectively complete the development and testing of our products targeted to the bio-chemical market, our ability to commercially produce our products on a profitable basis, commercial acceptance of our products, product price volatility, product demand, market competition and general economic conditions, and other factors described in the Company's filings with the Securities and Exchange Commission. We undertake no obligation and do not intend to revise or update publicly any forward looking statements for any reason.